RECRUITING

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.

Official Title

Molecular Fingerprinting of Lung Cancer

Quick Facts

Study Start:2001-05
Study Completion:2031-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00897117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 120 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

VICC Clinical Trials Information Program
CONTACT
800-811-8480
cip@vumc.org

Principal Investigator

Eric Grogan, MD
PRINCIPAL_INVESTIGATOR
Vanderbilt Medical Center

Study Locations (Sites)

Dan Rudy Cancer Center at Saint Thomas Hospital
Nashville, Tennessee, 37205
United States
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, 37212
United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838
United States

Collaborators and Investigators

Sponsor: Vanderbilt-Ingram Cancer Center

  • Eric Grogan, MD, PRINCIPAL_INVESTIGATOR, Vanderbilt Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2001-05
Study Completion Date2031-05-31

Study Record Updates

Study Start Date2001-05
Study Completion Date2031-05-31

Terms related to this study

Keywords Provided by Researchers

  • stage I non-small cell lung cancer
  • stage II non-small cell lung cancer

Additional Relevant MeSH Terms

  • Lung Cancer